 |
|
|
| |
Utilization and Effectiveness of Elbasvir/Grazoprevir for
the Treatment of Hepatitis C Virus Genotype 1b Infection:
Updated Cohort From the US Veteran Affairs Healthcare System
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Amy Puenpatom1; Jennifer R. Kramer2,3; Yumei Cao2; Hashem El-Serag2,3; Roshani Shah1;
Fashiha Kanwal2,3
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Michael E. DeBakey VA Medical Center, Houston, TX, USA;
3Baylor College of Medicine, Houston, TX, USA
|
| |
|
|
|
|
|
